We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-11.81%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.73M
AUM Growth
-$5.17B
Cap. Flow
-$776M
Cap. Flow %
-13,535.32%
Top 10 Hldgs %
49.82%
Holding
217
New
75
Increased
44
Reduced
24
Closed
41

Top Buys

Rank Stock Value
1
ORLY icon
O'Reilly Automotive
ORLY
+$93.9M
2
LULU icon
lululemon athletica
LULU
+$73.2M
3
DG icon
Dollar General
DG
+$71.9M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$67.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$62.2M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$105M
2
BIIB icon
Biogen
BIIB
+$68.7M
3
TGT icon
Target
TGT
+$68.3M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$62.1M
5
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
+$62M

Sector Composition

Rank Sector Weight
1 Healthcare 44.4%
2 Consumer Staples 8.91%
3 Consumer Discretionary 7.35%
4 Technology 4.07%
5 Communication Services 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UPH.WS
176
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$1 ﹤0.01%
10,000
– –
ADIL
177
Adial Pharmaceuticals
ADIL
$7.64M
– –
-2,908
Closed -$3.65M
AHCO icon
178
AdaptHealth
AHCO
$1.51B
– –
-500,000
Closed -$8.02M
ASMB icon
179
Assembly Biosciences
ASMB
$493M
– –
-166,667
Closed -$4.12M
ATER icon
180
Aterian
ATER
$4.61M
– –
-436,131
Closed -$12.7M
AYTU icon
181
AYTU BioPharma
AYTU
$24.5M
– –
-118,997
Closed -$2.57M
AZO icon
182
AutoZone
AZO
$49B
– –
-22,481
Closed -$46M
BBY icon
183
Best Buy
BBY
$17.7B
– –
-200,000
Closed -$18.2M
BOLT icon
184
Bolt Biotherapeutics
BOLT
$7.42M
– –
-20,000
Closed -$1.1M
CBUS icon
185
Cibus
CBUS
$145M
– –
-45,664
Closed -$2.38M
DECK icon
186
Deckers Outdoor
DECK
$13.5B
– –
-568,212
Closed -$25.9M
DT icon
187
Dynatrace
DT
$13B
– –
-212,000
Closed -$9.98M
FIVE icon
188
Five Below
FIVE
$11.8B
– –
-361,745
Closed -$57.3M
FTDR icon
189
Frontdoor
FTDR
$5.28B
– –
-692,000
Closed -$20.7M
HD icon
190
Home Depot
HD
$335B
– –
-349,897
Closed -$105M
IWM icon
191
PUT
iShares Russell 2000 ETF
IWM
$81.3B
– –
-28,000
Closed -$575M
JPM icon
192
JPMorgan Chase
JPM
$936B
– –
-150,000
Closed -$20.4M
NERV icon
193
Minerva Neurosciences
NERV
$191M
– –
-128,000
Closed -$850K
NRXP icon
194
NRX Pharmaceuticals
NRXP
$139M
– –
-625,978
Closed -$15.3M
OLPX
195
DELISTED
Olaplex Holdings
OLPX
– –
-636,000
Closed -$9.94M
PPC icon
196
Pilgrim's Pride
PPC
$6.7B
– –
-300,000
Closed -$7.53M
RH icon
197
RH
RH
$3.21B
– –
-49,913
Closed -$16.3M
SBFM
198
Sunshine Biopharma
SBFM
$2.76M
– –
-32
Closed -$1.56M
SBFMW
199
Sunshine Biopharma Inc Warrant
SBFMW
$94.9K
– –
-884,600
Closed -$876K
SNOW icon
200
Snowflake
SNOW
$108B
– –
-32,000
Closed -$7.33M
5 6 7
8
9

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Armistice Capital held 217 positions worth $5.73M, down 100% from $5.17B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital withdrew a net $776M in Q2 2022, closing 41 positions and reducing 24 holdings. Its most notable exit was Home Depot, an estimated $105M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 45% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in O'Reilly Automotive worth $92K.

  • Armistice Capital's largest Q2 2022 buy was O'Reilly Automotive: 2,183,715 shares worth $92K.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2022, an estimated $67.6M increase.
  • Armistice Capital's biggest Q2 2022 reduction was Biogen, cutting an estimated $68.7M.
  • Armistice Capital fully exited Home Depot in Q2 2022, selling an estimated $105M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.73M portfolio in Q2 2022.
  • Armistice Capital opened 75 new positions and closed 41 in Q2 2022.
  • Armistice Capital's portfolio value fell 100% quarter-over-quarter to $5.73M.

Based on Armistice Capital's 13F filing for Q2 2022, filed 15 Aug 2022.